# A Single Dose Study of SHR0410 in Healthy Male Participants

> **NCT03493191** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** 0.5μg/kg SHR0410
- **DRUG:** 1μg/kg SHR0410
- **DRUG:** 2μg/kg SHR0410
- **DRUG:** 5μg/kg SHR0410
- **DRUG:** 10μg/kg SHR0410
- **DRUG:** 20μg/kg SHR0410

## Key facts

- **NCT ID:** NCT03493191
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-15
- **Primary completion:** 2018-06-29
- **Final completion:** 2018-07-14
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493191, "A Single Dose Study of SHR0410 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03493191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*